Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization

Author:

Delatour Vincent1,Clouet-Foraison Noemie1,Gaie-Levrel François1,Marcovina Santica M2,Hoofnagle Andrew N3,Kuklenyik Zsuzsanna4,Caulfield Michael P5,Otvos James D6,Krauss Ronald M7,Kulkarni Krishnaji R8,Contois John H9,Remaley Alan T10,Vesper Hubert W4,Cobbaert Christa M11,Gillery Philippe12

Affiliation:

1. Laboratoire National de Métrologie et d'Essais (LNE), Paris, France

2. Northwest Lipid Metabolism and Diabetes Research Laboratories, University of Washington, Seattle, WA

3. Department of Laboratory Medicine, University of Washington, Seattle, WA

4. Centers for Disease Control and Prevention, Division of Laboratory Sciences, Atlanta, GA

5. Quest Diagnostics Nichols Institute, San Juan Capistrano, CA

6. Laboratory Corporation of America® Holdings, Morrisville, NC

7. Children Hospital Oakland Research Institute, Oakland, CA

8. VAP Diagnostics Laboratory Inc., Birmingham, AL

9. Sun Diagnostics, LLC, New Gloucester, ME

10. Lipoprotein Metabolism Section, National Heart, Lung, and Blood Institute, Bethesda, MD

11. Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, the Netherlands

12. University Hospital of Reims, Laboratory of Pediatric Biology and Research, Reims, France

Abstract

Abstract BACKGROUND Despite the usefulness of standard lipid parameters for cardiovascular disease risk assessment, undiagnosed residual risk remains high. Advanced lipoprotein testing (ALT) was developed to provide physicians with more predictive diagnostic tools. ALT methods separate and/or measure lipoproteins according to different parameters such as size, density, charge, or content, and equivalence of results across methods has not been demonstrated. METHODS Through a split-sample study, 25 clinical specimens (CSs) were assayed in 10 laboratories before and after freezing using the major ALT methods for non-HDL particles (non-HDL-P) or apolipoprotein B-100 (apoB-100) measurements with the intent to assess their comparability in the current state of the art. RESULTS The overall relative standard deviation (CV) of non-HDL-P and apoB-100 concentrations measured by electrospray differential mobility analysis, nuclear magnetic resonance, immunonephelometry, LC-MS/MS, and vertical autoprofile in the 25 frozen CSs was 14.1%. Within-method comparability was heterogeneous, and CV among 4 different LC-MS/MS methods was 11.4% for apoB-100. No significant effect of freezing and thawing was observed. CONCLUSIONS This study demonstrates that ALT methods do not yet provide equivalent results for the measurement of non-HDL-P and apoB-100. The better agreement between methods harmonized to the WHO/IFCC reference material suggests that standardizing ALT methods by use of a common commutable calibrator will improve cross-platform comparability. This study provides further evidence that LC-MS/MS is the most suitable candidate reference measurement procedure to standardize apoB-100 measurement, as it would provide results with SI traceability. The absence of freezing and thawing effect suggests that frozen serum pools could be used as secondary reference materials.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3